Adipose tissue is used by the body to store energy as fat. There are two kinds of adipose tissue, White Adipose Tissue (WAT) and Brown Adipose Tissue (BAT). They are more commonly known as white fat and brown fat.
Brown fat has been tagged as the "good" fat since it burns calories more than WAT. This type of fat is abundant in newborns and in hibernating mammals. Its primary function is to generate body heat in animals or newborns that do not shiver.
White adipose tissue is critical for the deposition of excessive fatty acids. This is where excess fat from food is stored, later to be released as energy. Excessive eating causes more fat to be stored and ultimately leads to obesity.
Why do fat cells get fat? New suspect Identified
As the world fights obesity at the human level, scientists at the University of Michigan and their colleagues have made a surprising finding at the microscopic level that could help fuel that fight.
Their work helps explain why fat-storing cells get fatter, and burn fat slower, as obesity sets in. If their findings from mice can be shown to apply to humans, they may provide a new target for obesity-fighting drugs.
By studying the tiny signals that fat-storing cells send to one another, the team has shown a crucial and previously unknown role for a molecule called Secreted frizzled-related protein 5 (SFRP5) .
The results, which appear online today and will be in the July issue of the Journal of Clinical Investigation, surprised them.
Video: Adipose
In a series of experiments, the team showed that Sfrp5 influences a signaling pathway known as WNT to stimulate fat cells – called adipocytes – to grow larger and to suppress the rate at which fat is burned in the mitochondria inside them.
By stopping cells from making Sfrp5, they were able to make mice that didn't get as fat as quickly because their adipocytes didn't grow large – even when the mice were fed a high-fat diet. They even showed the impact when transplanting fat from Sfrp5—deficient mice into other mice.
The research was performed with National Institutes of Health funding in the U-M Medical School laboratory of Ormond MacDougald, Ph.D., the Faulkner Professor in the Department of Molecular & Integrative Physiology, a professor of internal medicine and a member of U-M's Brehm Center for Diabetes Research.
Working with postdoctoral fellow and first author Hiroyuki Mori, Ph.D., and colleagues, MacDougald says the team built on its previous findings about the importance of WNT signaling in fat cell development.
"WNT signaling plays a crucial role in regulating, and inhibiting, white fat cell growth and the recruitment of new cells to store fat," he explains. "But it appears that in obesity, Sfrp5 can interfere with that signaling, and may create a feedback loop that keeps stimulating production of more of itself."
He notes that the new results contradict previous work published by another group, which found essentially the opposite role for Sfrp5. A commentary accompanying the new U-M paper, by scientists from Denmark, notes the strong evidence behind the new findings and emphasizes the importance of further research on the topic.
 |
| With obesity comes an increase in adipocyte cell size and number. This image of white adipose tissue shows fat storage cells (green) and nearby blood vessels (orange), with cell nuclei shown in blue. Credit: University of Michigan - MacDougald lab |
They were able to breed mice that could not make the molecule, and expected to see that these mice resisted obesity because they couldn't convert more cells into adipocytes to store excess fat from their high-fat diet.
But instead, they found that the mice without Sfrp5 did have just as many fat cells as other mice -- but that these cells didn't accumulate fat and grow bigger. As a result, the mice didn't get fat, no matter how rich their diet.
Looking more closely at Sfrp5-deficient mice, they saw a surge of activity in expression of genes related to mitochondria – the furnaces inside cells that burn fat or other fuel to power cell activity. It was as if the furnaces had been stoked when Sfrp5 wasn't present, so fat could be burned at a higher rate than normal.
"From our results, we believe that Sfrp5 is an important moderator of mitochondrial activity, the first time this has been seen for the WNT signaling pathway in adipocytes," says Mori. "This underscores the complexity of WNT signaling."
In essence, MacDougald says, Sfrp5 poses as a decoy receptor for WNT signals to bind to, keeping them from binding to the receptors on the cell surface that they otherwise would bind to. With WNT signaling reduced, cells store fat and grow larger, and don't burn it as quickly. Then, the cells produce even more Sfrp5, creating the feedback loop that perpetuates the tendency for adipocytes to accumulate lipid.
While pharmaceutical companies are already looking at WNT signaling as a possible target for drugs related to bone formation, the new findings suggest that perhaps the same signaling pathway could be a target for anti-obesity drugs.
But, MacDougald cautions, the findings need to be explored further in both mice and humans. With the obesity epidemic putting hundreds of millions of people at risk of all types of diseases, that research has a special urgency behind it.
RELATED LINKS
University of Michigan Health System
Journal of Clinical Investigation
National Institutes of Health
Brehm Center for Diabetes Research
Study On Ephedrine And Weight Loss May Lead To Wearable Diet Vest That Burns Fat
Ursolic Acid In Apple Peels Reduces Obesity And Associated Health Problems
The Supermarket May Influence One's Own Weight And Obesity
Scientists Present Proof Green Coffee Beans Help in Fast Effective Weight Loss
Avocado Oil - Healthy Treatment Against Aging And Harmful Free Radicals
Anti-Diabetic Medicine Beneficial in Prevention of Long Term Maternal Obesity
